Trial intelligence / Profile preview

Brain imaging in PTSD: paroxetine versus trauma-focused CBT

NL-OMON33322Not yet recruiting

Sponsor
Amsterdam University Medical Center
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of paroxetine in post-traumatic stress disorder (PTSD) (4 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Structural and functional imaging differences between PTSD patients and controls, Imaging differences after effective versus non-effective therapy and 3 more. Planned start Oct 2009; status: not yet recruiting.

02

Drugs

paroxetine
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NL-OMON33322.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON33322.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call